CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

80 hedge funds and large institutions have $71.2M invested in Cascadian Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 17 closing their positions.

Holders
80
Holders Change
-13
Holders Change %
-13.98%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
21
Reduced
22
Closed
17
Calls
$593K
Puts
$108K
Net Calls
+$485K
Net Calls Change
+$140K